Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0R1IL
|
||||
Former ID |
DNC012884
|
||||
Drug Name |
4-Naphthalen-2-yl-5-piperidin-4-yl-isoxazol-3-ol
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [527382] | ||
Structure |
Download2D MOL |
||||
Formula |
C18H18N2O2
|
||||
Canonical SMILES |
C1CNCCC1C2=C(C(=O)NO2)C3=CC4=CC=CC=C4C=C3
|
||||
InChI |
1S/C18H18N2O2/c21-18-16(17(22-20-18)13-7-9-19-10-8-13)15-6-5-12-3-1-2-4-14(12)11-15/h1-6,11,13,19H,7-10H2,(H,20,21)
|
||||
InChIKey |
PWDALQSYHZMANN-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Gamma-aminobutyric acid receptor subunit alpha-1 | Target Info | Inhibitor | [527382] | |
Gamma-aminobutyric acid receptor subunit beta-2 | Target Info | Inhibitor | [527382] | ||
Gamma-aminobutyric acid receptor subunit gamma-2 | Target Info | Inhibitor | [527382] | ||
Gamma-aminobutyric acid receptor | Target Info | Inhibitor | [527382] | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.